120 related articles for article (PubMed ID: 16219537)
41. The proportion of CD3- CD4+ T-cell population remained unaffected after corticosteroids treatment for lymphocytic variant hypereosinophilic syndrome (L-HES).
Helbig G; Wichary R; Razny M; Rodzaj M; Wozniczka K; Dziaczkowska-Suszek J; Kyrcz-Krzemien S
Scand J Immunol; 2010 Oct; 72(4):372-3. PubMed ID: 20883323
[No Abstract] [Full Text] [Related]
42. Eosinophilia Associated With CD3
Carpentier C; Verbanck S; Schandené L; Heimann P; Trépant AL; Cogan E; Roufosse F
Front Immunol; 2020; 11():1765. PubMed ID: 32849632
[No Abstract] [Full Text] [Related]
43. CD3
Carpentier C; Schandené L; Dewispelaere L; Heimann P; Cogan E; Roufosse F
J Allergy Clin Immunol Pract; 2021 Jun; 9(6):2426-2439.e7. PubMed ID: 33545400
[TBL] [Abstract][Full Text] [Related]
44. Conformational and biochemical differences in the TCR.CD3 complex of CD8(+) versus CD4(+) mature lymphocytes revealed in the absence of CD3gamma.
Zapata DA; Pacheco-Castro A; Torres PS; Ramiro AR; San José E; Alarcón B; Alibaud L; Rubin B; Toribio ML; Regueiro JR
J Biol Chem; 1999 Dec; 274(49):35119-28. PubMed ID: 10574994
[TBL] [Abstract][Full Text] [Related]
45. Lymphocytic variant of hypereosinophilic syndrome: A report of seven cases from a single institution.
Hu Z; Wang W; Thakral B; Chen Z; Estrov Z; Bueso-Ramos CE; Verstovsek S; Medeiros LJ; Wang SA
Cytometry B Clin Cytom; 2021 May; 100(3):352-360. PubMed ID: 32157815
[TBL] [Abstract][Full Text] [Related]
46. [Lymphocytic variant of the hypereosinophilic syndrome].
Roldán Montaud A; Citores Sánchez MJ; Perales Fraile I; Masip Marzá V; Bellas Menéndez C; Vargas Núñez JA
Rev Clin Esp; 2009 Jun; 209(6):303-8. PubMed ID: 19635254
[TBL] [Abstract][Full Text] [Related]
47. Proteolytic regulation of nuclear factor of activated T (NFAT) c2 cells and NFAT activity by caspase-3.
Wu W; Misra RS; Russell JQ; Flavell RA; Rincón M; Budd RC
J Biol Chem; 2006 Apr; 281(16):10682-90. PubMed ID: 16455648
[TBL] [Abstract][Full Text] [Related]
48. Differential contribution of NFATc2 and NFATc1 to TNF-alpha gene expression in T cells.
Kaminuma O; Kitamura F; Kitamura N; Hiroi T; Miyoshi H; Miyawaki A; Miyatake S
J Immunol; 2008 Jan; 180(1):319-26. PubMed ID: 18097033
[TBL] [Abstract][Full Text] [Related]
49. Variable presentation of primary immune deficiency: two cases with CD3 gamma deficiency presenting with only autoimmunity.
Tokgoz H; Caliskan U; Keles S; Reisli I; Guiu IS; Morgan NV
Pediatr Allergy Immunol; 2013 May; 24(3):257-62. PubMed ID: 23590417
[TBL] [Abstract][Full Text] [Related]
50. An orderly inactivation of intracellular retention signals controls surface expression of the T cell antigen receptor.
Delgado P; Alarcón B
J Exp Med; 2005 Feb; 201(4):555-66. PubMed ID: 15728236
[TBL] [Abstract][Full Text] [Related]
51. Digital NFATc2 activation per cell transforms graded T cell receptor activation into an all-or-none IL-2 expression.
Podtschaske M; Benary U; Zwinger S; Höfer T; Radbruch A; Baumgrass R
PLoS One; 2007 Sep; 2(9):e935. PubMed ID: 17895976
[TBL] [Abstract][Full Text] [Related]
52. Hypereosinophilic syndrome and cyclic oscillations in blood cell counts. A clonal disorder of hematopoiesis originating in a pluripotent stem cell.
Malcovati L; La Starza R; Merante S; Pietra D; Mecucci C; Cazzola M
Haematologica; 2004 Apr; 89(4):497-9. PubMed ID: 15075087
[TBL] [Abstract][Full Text] [Related]
53. The lymphoid variant of hypereosinophilic syndrome: study of 21 patients with CD3-CD4+ aberrant T-cell phenotype.
Lefèvre G; Copin MC; Staumont-Sallé D; Avenel-Audran M; Aubert H; Taieb A; Salles G; Maisonneuve H; Ghomari K; Ackerman F; Legrand F; Baruchel A; Launay D; Terriou L; Leclech C; Khouatra C; Morati-Hafsaoui C; Labalette M; Borie R; Cotton F; Gouellec NL; Morschhauser F; Trauet J; Roche-Lestienne C; Capron M; Hatron PY; Prin L; Kahn JE;
Medicine (Baltimore); 2014 Oct; 93(17):255-266. PubMed ID: 25398061
[TBL] [Abstract][Full Text] [Related]
54. NIK prevents the development of hypereosinophilic syndrome-like disease in mice independent of IKKα activation.
Häcker H; Chi L; Rehg JE; Redecke V
J Immunol; 2012 May; 188(9):4602-10. PubMed ID: 22474019
[TBL] [Abstract][Full Text] [Related]
55. Cyclical hypereosinophilia with skin manifestations and a clonal T cell population.
González Delgado P; de la Sen Fernández ML; Soriano Gomis V; Pérez Crespo M; Muñoz Ruiz C; Hernández Niveiro E
J Investig Allergol Clin Immunol; 2008; 18(5):401-3. PubMed ID: 18973106
[TBL] [Abstract][Full Text] [Related]
56. NF-kappaB in Th2 cells: delayed and long-lasting induction through the TCR complex.
Dorado B; Portolés P; Ballester S
Eur J Immunol; 1998 Jul; 28(7):2234-44. PubMed ID: 9692893
[TBL] [Abstract][Full Text] [Related]
57. [Idiopathic hypereosinophilic syndrome: from the clinic to the laboratory, from the laboratory to the clinic].
Roufosse F; Cogan E
Rev Med Brux; 2001 Apr; 22(2):A113-5. PubMed ID: 11388032
[No Abstract] [Full Text] [Related]
58. Eosinophilia associated with clonal T-cell proliferation.
Kitano K; Ichikawa N; Shimodaira S; Ito T; Ishida F; Kiyosawa K
Leuk Lymphoma; 1997 Oct; 27(3-4):335-42. PubMed ID: 9402331
[TBL] [Abstract][Full Text] [Related]
59. Identification of direct transcriptional targets of NFATC2 that promote β cell proliferation.
Simonett SP; Shin S; Herring JA; Bacher R; Smith LA; Dong C; Rabaglia ME; Stapleton DS; Schueler KL; Choi J; Bernstein MN; Turkewitz DR; Perez-Cervantes C; Spaeth J; Stein R; Tessem JS; Kendziorski C; Keleş S; Moskowitz IP; Keller MP; Attie AD
J Clin Invest; 2021 Nov; 131(21):. PubMed ID: 34491912
[TBL] [Abstract][Full Text] [Related]
60. [Change of T cell TCR-CD3 complex-mediated gene expression pattern in lead poisoning patients].
Wu L; Lin QY; Liu SC; Shen Q; Li B; Zhou JD; Yu W; Liu WW
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 Mar; 31(3):201-4. PubMed ID: 23510838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
